Arenaviruses for use in the treatment and/or prevention of tumors and method for producing arenaviruses with (improved) tumor-regression properties.

POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE

Live attenuated virus vaccines for la crosse virus and other bunyaviridae

Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors

Live attenuated vaccines for pneumoviruses and related methods and materials

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

Virus causing respiratory tract illness in susceptible mammals

Non-neuroinvasive viruses and uses thereof

Influenza virus vectors and uses therefor

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

Vaccines for porcine epidemic diarrhea virus infections

Adaptation of attenuated infectious bronchitis virus (IBV) to embryonic kidney cells and vaccine thereby produced

Chikagunya virus RNA vaccines

Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses

Tilapia lake virus vaccines

COMPOSITIONS AND METHODS FOR RAPID IMMUNIZATION AGAINST DENGUE VIRUS

RNA virus attenuation by alteration of mutational robustness and sequence space

Retargeted herpesvirus with a glycoprotein H fusion

Human ebola virus species and compositions and methods thereof

Circovirus sequences associated with piglet weight loss disease (PWD)

Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers

Dengue virus vaccine compositions and methods of use thereof

MODULATION OF REPLICATIVE FITNESS BY DEOPTIMIZATION OF SYNONYMOUS CODONS

CMV glycoproteins and recombinant vectors

Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof

Gene-modified measles virus for tumor treatment use

Zika virus RNA vaccines

Immunization agents and methods of use

Poxviral vaccines

Recombinant modified vaccinia virus Ankara (MVA) Respiratory Syncytial Virus (RSV) vaccine

Modified Sendai virus vaccine and imaging vector

Tri-segmented arenaviruses as vaccine vectors

Vaccine with reduced enhancement of viral infection

Sequence arrangements and sequences for neoepitope presentation

Adjuvant compositions

Vaccine compositions against dengue virus diseases

ATTENUATED ZIKA VIRUS CONSTRUCTS AND USES THEREOF

Viral vectors and their use in therapeutic methods

Compositions and methods for dengue virus chimeric constructs in vaccines

EQUINE DISEASE MODEL FOR HERPESVIRUS NEUROLOGIC DISEASE AND USES THEREOF

Attenuated bovine coronavirus and related vaccines

Modified bat influenza viruses and their uses

Vaccine comprising beta-herpesvirus

Vaccines against genital herpes simplex infections

MUTANT PORCINE EPIZOOTIC DIARRHEA VIRUS FOR USE IN A VACCINE

Transgenic Vero-CD4/CCR5 cell line

Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor

COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS

Protease-engineered Cancer Cell Spheres as an Immunotherapy to Treat Cancer and non-Cancer Diseases

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

Porcine reproductive and respiratory syndrome vaccine virus

RECOMBINANT MUMPS VIRUS VACCINE

Coronavirus

Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors

Methods and compositions for the prevention and treatment of influenza

Arenavirus vaccine

Method and compositions

PRIME-BOOST REGIMENS WITH A TLR4 AGONIST ADJUVANT AND A LENTIVIRAL VECTOR

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

Virus causing respiratory tract illness in susceptible mammals

Composite antigenic sequences and vaccines

Attenuated parvovirus vaccine for muscovy duck parvovirus and goose parvovirus (derzsy's disease)

Human rotavirus vaccine strains and diagnostics

Hybrid core feline vaccines

Replication defective adenovirus vector in vaccination

Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection

Genetically engineered swine influenza virus and uses thereof

Recombinant swine influenza virus and uses thereof

Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject

strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning

North American Porcine Reproductive and Respiratory Syndrome (PRRS) Virus and Uses Thereof

Attenuated African swine fever virus vaccine

Use of oil and water emulsions for increasing B cell responses with modified Vaccinia Ankara virus

Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection

Recombinant classical swine fever virus (CSFV) comprising substitution in the TAV epitope of the E2 protein

Attenuated recombinant vesicular stomatitis viruses comprising modified matrix proteins

Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins

Influenza virus vectors and uses therefor

Methods and compositions for live attenuated viruses

Influenza M2 protein mutant viruses as live influenza attenuated vaccines

Microorganisms for therapy

Replication-competent VSV-HIV Env vaccines

Hendra virus recombinant compositions and uses thereof

Cold-adapted-viral-attenuation (CAVA) and novel attenuated poliovirus strains

Compositions and methods for producing dendritic cells

Needle shaped body and method for manufacturing needle shaped body

Paramyxovirus Immunogens and Related Materials and Methods

Methods of making and using live attenuated viruses

Viral inhibitory nucleotide sequences and vaccines

Methods of making modified viral genomes

Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins

European PRRSV strain

Process for preparing an attenuated tetravalent dengue vaccine

Porcine parvovirus

Compositions, methods and uses for dengue virus serotype-4 constructs

Chimpanzee adenoviral vector-based filovirus vaccines

Smallpox vaccine for cancer treatment

Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine

M.tuberculosis vaccines

HERPES SIMPLEX VIRUS VACCINES

Koi herpesvirus vaccine

RNA interference functions as an antiviral immunity in mammals

VACCINE ADJUVANTS FOR CYTOMEGALOVIRUS PREVENTION AND TREATMENT

Swine virus vaccines that are liquid stable

Cytomegalovirus vaccines and methods of production

Live, attenuated vaccines and methods of making and using

Immunogenic compositions and methods

Avirulent, immunogenic flavivirus chimeras

Live attenuated virus vaccines for la crosse virus and other bunyaviridae

METHODS FOR INTRODUCING MUTATIONS THAT ALTER THE PROBABILITY OF INTRANUCLEIC ACID BASE PAIRING OF A CONSERVED STRUCTURED NUCLEOTIDE AND RELATED COMPOSITIONS

Live-attenuated virus and methods of production and use

Tilapia lake virus vaccines

Poultry virus vaccines that are liquid stable

SEMI-LIVE RESPIRATORY SYNCYTIAL VIRUS VACCINE

Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors

Purification of herpes virus

Recombinant rift valley fever (RVF) viruses and methods of use

Excipients for stabilising viral particles, polypeptides or biological material

Method of attenuating porcine pseudorabies virus, attenuated strains of porcine pseudorabies virus, vaccine composition and use thereof

Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof

PRRS virus variant, European PRRS virus cDNA clone, and uses thereof

Compositions and methods for vaccination against influenza A virus

Immortalized porcine alveolar macrophage

CMV vaccines

SWINE INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica

Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof

USE OF RAPAMYCIN AS VACCINE ADJUVANT AND PREPARATION METHOD THEREFOR

Gene-Deleted Variant Strain Of Porcine Pseudorabies Virus, Vaccine Composition, Method Of Making The Same And Use Thereof

Method of attenuating porcine pseudorabies virus, attenuated strains of porcine pseudorabies virus, vaccine composition and use thereof

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

Live attenuated infectious laryngotracheitis virus (ILTV) vaccines and preparation thereof

Tissue targeted antigenic activation of the immune response to treat cancers

Thermostable respiratory synctial virus (RSV) vaccine compositions

Bivalent swine influenza virus vaccine

Virus causing respiratory tract illness in susceptible mammals

Nasal mucosal vaccine composition

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) AND VACCINES

Influenza virus mutants and uses therefor

Influenza virus mutants and uses therefor

Dry formulations of vaccines that are room temperature stable

Methods to improve vector expression and genetic stability

HIV-1 vaccine

CYTOMEGALOVIRUS-BASED IMMUNOGENIC PREPARATIONS

High titer recombinant influenza viruses for vaccines

Methods and compositions related to reorganization of arenavirus genome for development of novel arenavirus live-attenuated vaccines (LAV)

Bacterial artificial chromosomes

Methods of immunization with varicella zoster virus antigen

Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors

Vaccines for diseases caused by viruses of the family of reoviridae

Method for selecting a permissive cell line for replicating avian viruses

Dengue virus vaccine compositions and methods of use thereof

Modified matrix proteins of vesicular stomatitis virus

Live attenuated vaccines for influenza viruses

Attenuated influenza vaccines and uses thereof

Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof

Compositions and methods for administration of vaccines against dengue virus

Attenuated swine influenza vaccines and methods of making and use thereof

Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus

Recombinant HCMV and RHCMV vectors and uses thereof

Attenuated vaccinia virus KVAC103 strain

Adaptation of attenuated infectious bronchitis virus (IBV) to embryonic kidney cells and vaccine thereby produced

Vaccine composition

Neutralizing molecules to influenza viruses

LONE STAR VIRUS

Porcine reproductive and respiratory syndrome virus compositions and uses thereof

Infectious DNA vaccines against chikungunya virus

METHODS AND DEVICES FOR CANINE HERPESVIRUS 1 (CHV-1) DETECTION AND PREVENTION

H3 influenza a virus

Prefusion RSV F proteins and their use

Vaccine against bovine leukemia virus

Formulations

immunogens and related materials and methods

Attenuation of infectious bronchitis virus variant GA-13

Bovine virus vaccines that are liquid stable

Recombinant RSV with silent mutations, vaccines, and methods related thereto

Swine influenza viruses and constructs and uses thereof

Rapid and prolonged immunologic-therapeutic

Conditionally replication deficient herpes virus and use thereof in vaccines

Tropism modified cancer terminator virus (Ad.5/3 CTV;AD.5/3-CTV-M7)

Neuroattenuated herpes simplex virus

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy

Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens

Tissue targeted antigenic activation of the immune response to treat cancers

Modified human rotaviruses and uses therefor

Coating Method and Materials

Compositions, methods of administration and uses for trivalent dengue virus formulations

Influenza viruses with mutant PB2 segment as live attenuated vaccines

Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus

Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof

Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida

HSV-1 and HSV-2 vaccines and methods of use thereof

Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions

Genetically engineered swine influenza virus and uses thereof

Universal influenza vaccine based on heterologous multiple M2E proteins

VACCINATION AGAINST JAPANESE ENCEPHALITIS, MEASLES, MUMPS AND RUBELLA

MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells

Liquid stable virus vaccines

Porcine parvovirus 5A, methods of use and vaccine

Recombinant measles virus expressing chikungunya virus polypeptides and their applications

ATTENUATED INFLUENZA VACCINES AND USES THEREOF

Human Ebola virus species and compositions and methods thereof

MVA vaccine for delivery of a UL128 complex and preventing CMV infection

Attenuated parvovirus vaccine for Muscovy duck parvovirus and goose parvovirus (Derzsys disease)

Medicaments and methods for treating mesothelioma

Immunization with rabies virus vector expressing foreign protein antigen

Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine

Rift valley fever virus replicon particles and use thereof

Production of infectious influenza viruses

Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof

Arterivirus protein and expression mechanisms

Methods of vaccine administration

Circovirus sequences associated with piglet weight loss disease (PWD)

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

Circovirus sequences associated with piglet weight loss disease (PWD)

Recombinant influenza vectors with tandem transcription units

CD2 DEFICIENT AFRICAN SWINE FEVER VIRUS AS LIVE ATTENUATED OR SUBSEQUENTLY INACTIVATED VACCINE AGAINST AFRICAN SWINE FEVER IN MAMMALS

Composition comprising a colloidal synthetic bioresorbable vector and a viral vector

Herpesvirus compositions and related methods

Compositions and methods for rapid immunization against dengue virus

AUTOLOGOUS BIOLOGICAL CANCER VACCINE

Anti-HIV vaccine constructed based on amino acid mutations in attenuated live EIAV vaccine

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

Human rotavirus vaccine strains and diagnostics

Paramyxovirus immunogens and related materials and methods

Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection

Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein

Equine encephalitis virus vaccines and methods of using thereof

Flavivirus vaccines

HCV vaccines and methods for using the same

H3 influenza A virus

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

Attenuated recombinant vesicular stomatitis viruses comprising modified mutant matrix proteins

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents

THERAPEUTIC VACCINATION AGAINST ACTIVE TUBERCULOSIS

Herpes simplex virus vaccines

Infectious CDNA clone of european PRRS virus and uses thereof

CMV glycoproteins and recombinant vectors

Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof

METHODS AND COMPOSITIONS FOR LIVE ATTENUATED VIRUSES

Compositions and methods for dengue virus chimeric constructs in vaccines

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

Microorganisms for therapy

Compositions and methods for live, attenuated alphavirus formulations

Liquid stable bovine virus vaccines

Bovine virus vaccines that are liquid stable

Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use

European PRRSV strain

LIQUID VACCINE PREPARATIONS

Composition

Viruses lacking epithelial cell receptor entry

Live attenuated chimeric porcine circovirus vaccine

Conditional replicating cytomegalovirus as a vaccine for CMV

Multivalent vaccines for rabies virus and filoviruses

Influenza B viruses having alterations in the hemagglutinin polypeptide

Recombinant vaccine against PRRS in a viral vector

Modified Sendai virus vaccine and imaging vector

T-cell vaccination with viral vectors via mechanical epidermal disruption

Porcine reproductive and respiratory syndrome virus compositions and uses thereof

Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity

Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors

Cellular permissivity factor for viruses and uses thereof

Rapid and prolonged immunologic-therapeutic

Avirulent, immunogenic flavivirus chimeras

Method for producing vaccinal viral strain of a virus of the family

Multi plasmid system for the production of influenza virus

Recombinant rift valley fever (RVF) viruses and methods

Compositions, methods and uses for dengue virus serotype-4 constructs

Compositions and methods for vaccinating cattle

Influenza virus mutants and uses therefor

Vaccination method employing genetically stable attenuated polioviruses comprising multiple mutations in domain V of the 5′ noncoding region

Combined vaccines for prevention of porcine virus infections

Compositions for canine respiratory disease complex

Influenza hemagglutinin and neuraminidase variants

North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof

Liquid stable virus vaccines

Adjuvant compositions

Crimean-Congo hemorrhagic fever virus vaccine

Modified influenza virus for monitoring and improving vaccine efficiency

Attenuated swine influenza vaccines and methods of making and use thereof

Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

Adenovirus serotype 26 and serotype 35 filovirus vaccines

Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

Recombinant mumps virus vaccine

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

Inactivated poliovaccine

Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning

Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions

Compositions and methods for treating viral infections

Recombinant bicistronic flavivirus vectors

Vaccines for inclusion body hepatitis

ORF7 deficient varicella virus, vaccine comprising the virus and use thereof

Vaccines with live bacterial isolates for systemic administration

Methods to improve vector expression and genetic stability

Recombinant rift valley fever virus encoding a dominant-negative inhibitor of DSRNA-dependent protein kinase in the NSS region